Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer
Status: SUSPENDED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Docetaxel|DRUG: Capecitabine|DRUG: Cyclophosphamide (tablet)|DRUG: Fluorouracil|DRUG: Epirubicin|DRUG: Cyclophosphamide (injection)
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University